ALNY Data
Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY) » Social Data - Financial Data - Research - Charts
-
$ALNY | Alnylam Pharmaceuticals, Inc. Social Data » 1) Follower Data, 2) Sentiment Data, 3) Posts Data | Data Mined from SpeculatingStocks Pulse Social Network
Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.
ALNY Follower Data
Followers: 1
ALNY Sentiment Data
'Buys': 0 | 'Sells': 0
'Buys' Yesterday: 0 | 'Sells' Yesterday: 0
B/S Rating Today: 0 | B/S Rating All-Time: 0
ALNY Posts Data
Avg. Number of Pulses a Day: 0.89 | Total Number of Pulses All-Time: 1090
Total Number of Pulses Yesterday: 1
More: $ALNY (Alnylam Pharmaceuticals, Inc.) Stream, Posts, and Sentiment Page
ALNY Financial Data
-
ALNY | Alnylam Pharmaceuticals, Inc. Financial Data » 1) Annual Financials, 2) Quarterly Financials, and 3) Key Metrics
Market Cap: $9.602B
ALNY Annual Financials (Most Recent Fiscal Year)
Income Statement:Revenue: $89.91M
Net Income: $(490.87M)
Cash Flow Statement:
Change in Cash / Cash Equiv.: $451.74M
Balance Sheet:
Cash / Cash Equiv. + ST Investments: $1.69B
Short Term Debt: None
Long Term Debt: $30M
Total Current Assets: $1.76B
Total Current Liabilities: $144.25M
Total Assets: $1.99B
Total Liabilities: $228.3M
Stockholder Equity: $1.77B
Annual ALNY Cash Flow Statement
ALNY Quarterly Financials (Most Recent Q)
Income Statement:
Revenue: $37.92M
Net Income: $(142.23M)
Cash Flow Statement:
Change in Cash / Cash Equiv.: $443.32M
Balance Sheet:
Cash / Cash Equiv. + ST Investments: $1.69B
Short Term Debt: None
Long Term Debt: $30M
Total Current Assets: $1.76B
Total Current Liabilities: $144.25M
Total Assets: $1.99B
Total Liabilities: $228.3M
Stockholder Equity: $1.77B
Quarterly ALNY Income Statement
Quarterly ALNY Cash Flow Statement
ALNY Key Metrics
Market Cap: $9.602B
Trailing PE: N/A
Price to Sales (Based on Most Recent Annual Revenue): 106.8
Price to Book (Based on Most Recent Quarter Stockholder Equity): 5.42
Beta: 3.26
More Key ALNY Financial Metrics
Please Give Tips to Others about Insight Gained from ALNY Financials
Share: 1) Share Your Opinion of ALNY, 2) Place a 'Buy' or 'Sell' Sentiment on ALNY
ALNY Research
-
ALNY | Alnylam Pharmaceuticals, Inc. Research » 1) Share Data, 2) Short Data, 3) Insider Data, and 4) Corporate Data
ALNY Share Data
Outstanding Shares: 100.17M
Shares in Float: 47.42M
ALNY Short Data
Percent of Float Short: N/A
Shares Short: N/A
ALNY Insider Data
Shares Held by Insiders: 0.44%
Shares Held by Institutions: 98.24%
ALNY Corporate Data
CEO: Mr. Barry E. Greene
Employees: 749
Please Give Tips to Others about Insight Gained from ALNY Research
Share: 1) Share Your Opinion of ALNY, 2) Place a 'Buy' or 'Sell' Sentiment on ALNY

ALNY Charts
-
ALNY | Alnylam Pharmaceuticals, Inc. Charts » 1) 10-Year, 2) 5-Year, 3) 1-Year, 4) 6-Month, 5) 3-Month, 6) 1-Month, 7) 1-Day
ALNY 10-Year Chart
ALNY 5-Year Chart
ALNY 1-Year Chart
ALNY 6-Month Chart
ALNY 3-Month Chart
ALNY 1-Month Chart
ALNY 1-Day Chart
↻ Update ALNY Data to Most Recent
↻ Update ALNY Symbol Stream

ALNY Social Data